Upcoming Articles SPECIAL FEATURE ACR Appropriateness Criteria®—Anal Cancer
ATTENTION AUTHORS: New Manuscript Submission Guidelines Effective Immediately Gastrointestinal Cancer Research (GCR) is once again accepting direct-to-publisher manuscript submissions, and will no longer be using the Rapid Review manuscript submission and peerreview tracking system. Henceforth, authors wishing to submit their work for consideration to GCR should send all manuscripts and associated files via e-mail to Editor-in-Chief Daniel G. Haller, MD, c/o Donna Ogilvie at donna.ogilvie@ isgio.org. Please type “ATTN: Daniel G. Haller” in the Subject area of the message header to ensure that your communication is immediately recognized as a manuscript submission and that it is promptly processed accordingly. Any files too large to transmit via e-mail can be downloaded to GCR’s FTP site. Please contact the office for information and instructions on how to download large files. Please visit www.mygcronline.org and click on “SUBMIT ARTICLES” for complete manuscript submission guidelines. Read carefully and follow the simple manuscript preparation requirements outlined in the “INSTRUCTIONS FOR AUTHORS” window. Manuscripts that conform to GCR’s submission format will be forwarded to Dr. Haller for initial review and consideration.
Theodore S. Hong, Jennifer L. Pretz, Joseph M. Herman, May Abdel-Wahab, Nilofer Azad, A. William Blackstock, Prajnan Das, Karyn A. Goodman, Salma K. Jabbour, William E. Jones III, Andre A. Konski, Albert C. Koong, Miguel Rodriguez-Bigas, William Small, Jr, Charles R. Thomas, Jr, Jennifer Zook, W. Warren Suh
ORIGINAL RESEARCH Accelerated Fraction Radiotherapy with Capecitabine as Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer Samhita Chakraborty, Monica M. Morris, Todd W. Bauer, Reid B. Adams, Edward B. Stelow, Gina Petroni, Hanna K. Sanoff
KRAS G13D Mutation and Sensitivity to Cetuximab or Panitumumab in a Colorectal Cancer Cell Line Model Shalini Sree Kumar, Timothy J. Price, Omar Mohyieldin, Matthew Borg, Amanda Townsend, Jennifer E. Hardingham
Overexpression of the HER2/neu Gene: A New Therapeutic Possibility for Patients with Advanced Gallbladder Cancer? Iva´n Roa, Gonzalo de Toro, Kurt Schalper, Xabier de Aretxabala, Chaitanya Churi, Milind Javle
GI CANCER EDUCATIONAL CASE SERIES A Woman With Metastatic Pancreatic Neuroendocrine Tumor
Should you have questions or encounter any problems in submitting your work, please feel free to call our office or send enquiries via e-mail. CONTACT INFORMATION Donna Ogilvie Director of Operations International Society of Gastrointestinal Oncology 200 Broadhollow Road, Suite 207 Melville, NY 11747 Phone: 631-390-8390 Fax: 631-393-5026 E-mail: [email protected]
September–December 2013
www.myGCRonline.org
159
ATTENTION AUTHORS: New Manuscript Submission Guidelines Effective Immediately Gastrointestinal Cancer Research (GCR) is once again accepting direct-to-publisher manuscript submissions, and will no longer be using the Rapid Review manuscript submission and peerreview tracking system. Henceforth, authors wishing to submit their work for consideration to GCR should send all manuscripts and associated files via e-mail to Editor-in-Chief Daniel G. Haller, MD, c/o Donna Ogilvie at donna.ogilvie@ isgio.org. Please type “ATTN: Daniel G. Haller” in the Subject area of the message header to ensure that your communication is immediately recognized as a manuscript submission and that it is promptly processed accordingly. Any files too large to transmit via e-mail can be downloaded to GCR’s FTP site. Please contact the office for information and instructions on how to download large files. Please visit www.mygcronline.org and click on “SUBMIT ARTICLES” for complete manuscript submission guidelines. Read carefully and follow the simple manuscript preparation requirements outlined in the “INSTRUCTIONS FOR AUTHORS” window. Manuscripts that conform to GCR’s submission format will be forwarded to Dr. Haller for initial review and consideration.
Theodore S. Hong, Jennifer L. Pretz, Joseph M. Herman, May Abdel-Wahab, Nilofer Azad, A. William Blackstock, Prajnan Das, Karyn A. Goodman, Salma K. Jabbour, William E. Jones III, Andre A. Konski, Albert C. Koong, Miguel Rodriguez-Bigas, William Small, Jr, Charles R. Thomas, Jr, Jennifer Zook, W. Warren Suh
ORIGINAL RESEARCH Accelerated Fraction Radiotherapy with Capecitabine as Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer Samhita Chakraborty, Monica M. Morris, Todd W. Bauer, Reid B. Adams, Edward B. Stelow, Gina Petroni, Hanna K. Sanoff
KRAS G13D Mutation and Sensitivity to Cetuximab or Panitumumab in a Colorectal Cancer Cell Line Model Shalini Sree Kumar, Timothy J. Price, Omar Mohyieldin, Matthew Borg, Amanda Townsend, Jennifer E. Hardingham
Overexpression of the HER2/neu Gene: A New Therapeutic Possibility for Patients with Advanced Gallbladder Cancer? Iva´n Roa, Gonzalo de Toro, Kurt Schalper, Xabier de Aretxabala, Chaitanya Churi, Milind Javle
GI CANCER EDUCATIONAL CASE SERIES A Woman With Metastatic Pancreatic Neuroendocrine Tumor
Should you have questions or encounter any problems in submitting your work, please feel free to call our office or send enquiries via e-mail. CONTACT INFORMATION Donna Ogilvie Director of Operations International Society of Gastrointestinal Oncology 200 Broadhollow Road, Suite 207 Melville, NY 11747 Phone: 631-390-8390 Fax: 631-393-5026 E-mail: [email protected]
September–December 2013
www.myGCRonline.org
159
